NM_004999.4:c.2658+20A>C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_004999.4(MYO6):​c.2658+20A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0102 in 1,600,182 control chromosomes in the GnomAD database, including 757 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.013 ( 74 hom., cov: 32)
Exomes 𝑓: 0.0099 ( 683 hom. )

Consequence

MYO6
NM_004999.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.288

Publications

2 publications found
Variant links:
Genes affected
MYO6 (HGNC:7605): (myosin VI) This gene encodes a reverse-direction motor protein that moves toward the minus end of actin filaments and plays a role in intracellular vesicle and organelle transport. The protein consists of a motor domain containing an ATP- and an actin-binding site and a globular tail which interacts with other proteins. This protein maintains the structural integrity of inner ear hair cells and mutations in this gene cause non-syndromic autosomal dominant and recessive hearing loss. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2014]
MYO6 Gene-Disease associations (from GenCC):
  • autosomal dominant nonsyndromic hearing loss 22
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • nonsyndromic genetic hearing loss
    Inheritance: AD, AR Classification: DEFINITIVE, MODERATE Submitted by: ClinGen, G2P
  • autosomal recessive nonsyndromic hearing loss 37
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • autosomal dominant nonsyndromic hearing loss
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • progressive sensorineural hearing loss-hypertrophic cardiomyopathy syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 6-75887014-A-C is Benign according to our data. Variant chr6-75887014-A-C is described in ClinVar as Benign. ClinVar VariationId is 45148.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.138 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MYO6NM_004999.4 linkc.2658+20A>C intron_variant Intron 25 of 34 ENST00000369977.8 NP_004990.3 Q9UM54-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MYO6ENST00000369977.8 linkc.2658+20A>C intron_variant Intron 25 of 34 1 NM_004999.4 ENSP00000358994.3 Q9UM54-1

Frequencies

GnomAD3 genomes
AF:
0.0131
AC:
1995
AN:
152164
Hom.:
73
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000338
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0128
Gnomad ASJ
AF:
0.00749
Gnomad EAS
AF:
0.146
Gnomad SAS
AF:
0.0207
Gnomad FIN
AF:
0.0699
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00200
Gnomad OTH
AF:
0.0115
GnomAD2 exomes
AF:
0.0257
AC:
6435
AN:
250096
AF XY:
0.0245
show subpopulations
Gnomad AFR exome
AF:
0.000313
Gnomad AMR exome
AF:
0.0330
Gnomad ASJ exome
AF:
0.00765
Gnomad EAS exome
AF:
0.153
Gnomad FIN exome
AF:
0.0650
Gnomad NFE exome
AF:
0.00294
Gnomad OTH exome
AF:
0.0162
GnomAD4 exome
AF:
0.00994
AC:
14386
AN:
1447900
Hom.:
683
Cov.:
28
AF XY:
0.0100
AC XY:
7220
AN XY:
721258
show subpopulations
African (AFR)
AF:
0.000180
AC:
6
AN:
33312
American (AMR)
AF:
0.0300
AC:
1337
AN:
44638
Ashkenazi Jewish (ASJ)
AF:
0.00661
AC:
172
AN:
26038
East Asian (EAS)
AF:
0.153
AC:
6047
AN:
39528
South Asian (SAS)
AF:
0.0178
AC:
1523
AN:
85724
European-Finnish (FIN)
AF:
0.0612
AC:
3251
AN:
53156
Middle Eastern (MID)
AF:
0.00209
AC:
12
AN:
5732
European-Non Finnish (NFE)
AF:
0.00111
AC:
1220
AN:
1099808
Other (OTH)
AF:
0.0136
AC:
818
AN:
59964
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
685
1369
2054
2738
3423
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
168
336
504
672
840
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0131
AC:
1996
AN:
152282
Hom.:
74
Cov.:
32
AF XY:
0.0166
AC XY:
1234
AN XY:
74452
show subpopulations
African (AFR)
AF:
0.000337
AC:
14
AN:
41576
American (AMR)
AF:
0.0129
AC:
198
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00749
AC:
26
AN:
3470
East Asian (EAS)
AF:
0.146
AC:
758
AN:
5184
South Asian (SAS)
AF:
0.0205
AC:
99
AN:
4826
European-Finnish (FIN)
AF:
0.0699
AC:
741
AN:
10594
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00200
AC:
136
AN:
68014
Other (OTH)
AF:
0.0114
AC:
24
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
96
192
287
383
479
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00436
Hom.:
1
Bravo
AF:
0.0101
Asia WGS
AF:
0.0720
AC:
250
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 29, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Apr 23, 2010
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Changed to benign based on frequency -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
2.7
DANN
Benign
0.38
PhyloP100
0.29
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2295937; hg19: chr6-76596731; COSMIC: COSV64121593; COSMIC: COSV64121593; API